STOCK TITAN

Nocturne Acquisition Corporation - $MBTC STOCK NEWS

Welcome to our dedicated page for Nocturne Acquisition Corporation news (Ticker: $MBTC), a resource for investors and traders seeking the latest updates and insights on Nocturne Acquisition Corporation stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Nocturne Acquisition Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Nocturne Acquisition Corporation's position in the market.

Rhea-AI Summary
Nocturne Acquisition Corp. (NASDAQ:MBTCU) has postponed the Extraordinary General Meeting for the proposed business combination with Cognos Therapeutics, Inc. to February 6, 2024. The meeting will be held virtually, and shareholders can continue to vote on the proposals. The record date for the meeting remains December 29, 2023, and shareholders who have already voted need not take any action. The deadline for redemption rights has been extended to two business days before the meeting.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
23.5%
Tags
-
Rhea-AI Summary
Nocturne Acquisition Corporation (NASDAQ:MBTC) has submitted a registration statement to the SEC for a proposed business combination with Cognos Therapeutics, Inc. The combination aims to accelerate the research and advancement of Cognos' implantable drug delivery pump for the treatment of brain cancers and neurological diseases. The transaction is expected to close in Q4 2023 and the combined company will be renamed Cognos Therapeutics Holdings, Inc.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.18%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.47%
Tags
Nocturne Acquisition Corporation

Nasdaq:MBTC

MBTC Rankings

MBTC Stock Data

60.53M
1.70M
76.5%
16.46%
0.04%
Shell Companies
Financial Services
Link
United States
Wilmington

About MBTC

led by experienced technology and crypto operators, nocturne will leverage its deep industry expertise and vast global network to identify unique, public ready opportunities. our mission is to partner with a crypto or ai tech company that will enable the next frontier of innovation.